The Ohio State University Division of Epidemiology, Columbus, OH.
Ibis Reproductive Health, Oakland, CA.
Afr J Reprod Health. 2023 Jan;27(1):84-94. doi: 10.29063/ajrh2023/v27i1.8.
Medication abortion, a safe and effective method for terminating pregnancy in the first and second trimester, can reduce overall maternal mortality. However, little is known about how advocates for abortion view medication abortion in their communities, particularly where abortion is legally restricted. We conducted in-depth interviews (2018-2019; N=24) with health workers and community leaders in the Democratic Republic of the Congo, Kenya, Nigeria, Malawi, and Tanzania identified from the Mobilizing Activists Around Medication Abortion (MAMA) network. Interviews focused on the role of advocacy in medication abortion provision. Participants identified benefits of medication abortion to women, including privacy, accessibility, and safety, and community benefits, including perceived reduction in maternal mortality. Participants described challenges to providing support for medication abortion, including difficulties operating in legally restrictive environments and stigma. Findings highlight the role of grassroots advocacy to overcome challenges and provide an alternative model of abortion access and care to women.
药物流产是一种安全有效的终止妊娠方法,适用于第一和第二孕期,可以降低整体产妇死亡率。然而,对于堕胎在法律上受到限制的地方,倡导者如何看待社区内的药物流产,我们知之甚少。我们对来自动员围绕药物流产的倡导者网络(MAMA)的刚果民主共和国、肯尼亚、尼日利亚、马拉维和坦桑尼亚的卫生工作者和社区领导人进行了深入访谈(2018-2019 年;N=24)。访谈重点关注倡导在药物流产提供方面的作用。参与者确定了药物流产对妇女的好处,包括隐私、可及性和安全性,以及社区好处,包括认为降低了产妇死亡率。参与者描述了为药物流产提供支持所面临的挑战,包括在法律限制环境中运作的困难和耻辱感。研究结果强调了基层倡导的作用,以克服挑战并为妇女提供替代的堕胎机会和护理模式。